Half a decade after Abcam quit its 270 million pound sterling pursuit of Horizon Discovery, the British antibody research expert has potentially found itself on the opposite end of the dealmaking ...
CAMBRIDGE, England, April 13, 2026 /PRNewswire/ -- Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, today announced SimpleStep Ignite™ ELISA, a next ...
As British research supplies and tools provider Abcam moves toward a potential multibillion-dollar sale, one of the company's founders and major shareholders is pushing back. Dr. Jonathan Milner, an ...
Life sciences company Abcam is one of Glassdoor's happiest places to work in the UK. The company is growing and hired around 500 people during the pandemic. One of its top recruiters offered five tips ...
Horizon Discovery has rejected a £270 million ($367 million) takeover bid from Abcam. The gene editing specialist issued a strongly-worded rebuttal of the offer after Abcam went public with its plan, ...
CAMBRIDGE, United Kingdom, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Abcam plc (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, announces that, following release on 14 ...
Abcam PLC (NASDAQ:ABCM) is a $3.8 billion market cap biotechnology stock on the Nasdaq Global Select Market. It is moving its primary listing from Londons AIM (previously known as the Alternative ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Abcam has defended the handling of its proposed $5.7bn takeover by Danaher, insisting that the UK life sciences ...
Abcam operates in some highly attractive end markets, but its operational execution is not what it should be, according to its funder and former director. Dr. Jonathan Milner has called for the ...
For more than a decade, Abcam has been known as the “Amazon of Antibodies” because of its selection of over 110,000 products to research protein targets, from antibodies to proteins, lysates, ...
Back in June, Abcam’s CEO Alan Hirzel and his predecessor, founder Jonathan Milner, PhD, resolved a bitter battle over the company’s direction by agreeing to explore strategic alternatives. One of ...
Abcam, a supplier of protein research material and kits, has teamed up with bioanalytical measurement solutions expert Molecular Devices to develop screening tools for the life science industry. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results